More tools:Markets·Screener·Research·Chat

Dyadic International, Inc. (DYAI) Financial Statements

Dyadic International, Inc.
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001SJV0D6
XNAS · usd
0.51▼ 0.01 (-2.71%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close0.52
Day's Range0.51 – 0.58
52-Week Range0.48 – 1.60
Volume145.9K
Avg Volume185.7K
Share Statistics
Shares Outstanding
Employees5
ExchangeXNAS
Listed2004-11-05
Share count as of August 11, 2026
Loading Income Statement…
Key questions about Dyadic International, Inc. (DYAI)
What is Dyadic International, Inc.'s Market Cap?
Dyadic International, Inc.'s Market Cap is $18.4M, based on as-reported figures from SEC (XBRL) filings.
What is Dyadic International, Inc.'s Enterprise Value?
Dyadic International, Inc.'s Enterprise Value is $15.3M, based on as-reported figures from SEC (XBRL) filings.
What is Dyadic International, Inc.'s Price / Sales?
Dyadic International, Inc.'s Price / Sales is 4.8×, based on as-reported figures from SEC (XBRL) filings.
What is Dyadic International, Inc.'s EV / Revenue?
Dyadic International, Inc.'s EV / Revenue is 4.0×, based on as-reported figures from SEC (XBRL) filings.
What is Dyadic International, Inc.'s Revenue (TTM)?
Dyadic International, Inc.'s Revenue (TTM) is $3.8M, based on as-reported figures from SEC (XBRL) filings.
What is Dyadic International, Inc.'s Net Income (TTM)?
Dyadic International, Inc.'s Net Income (TTM) is -$7.6M, based on as-reported figures from SEC (XBRL) filings.
What is Dyadic International, Inc.'s Diluted EPS (TTM)?
Dyadic International, Inc.'s Diluted EPS (TTM) is -0.21, based on as-reported figures from SEC (XBRL) filings.
What is Dyadic International, Inc.'s Net Debt?
Dyadic International, Inc.'s Net Debt is -$3.1M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Revenue from Contract with Customer, Excluding Assessed Tax
YoY growth-0.6%+182.3%-30.8%-40.5%
Costs and expenses:
Costs of research and development revenue
Costs of grant revenue
Research and Development Expense
Selling, General and Administrative Expense
Foreign currency exchange (gain) loss——
Total costs and expenses
% of revenue313.7%271.3%371.6%265.3%
Loss from operations
% of revenue-213.7%-171.3%-271.6%-165.3%
Other income (expense):
Interest and Dividend Income (Non-Bank)
Interest expense————
Total other expense, net
Net loss
% of revenue-221.0%-175.9%-277.1%-169.7%
Earnings Per Share (Basic)
Earnings Per Share (Diluted)